TXMD (TherapeuticsMD Corp) מחיר חזוי לרווח

לוגו תאגידי של חברת TherapeuticsMD (TXMD)

TherapeuticsMD, Inc. (TXMD) price action is subject to the influence of high debt and delisting threats. Changes in the company's expected P/E highlight pressure from generics and the struggle for insurance coverage. A lack of new R&D developments limits growth, and the value of 0.00 shows the current magnitude of this multiple, helping to assess whether a systemic business decline is hidden behind the low price.

יחס מחיר לרווח חזוי: therapeuticsmd.com (TXMD) עבור 04.07.2022 - 15.11.2026

פילוחי נתונים אנליטיים מרוכזים עבור therapeuticsmd.com (TXMD)

אנליטיקה מסכמת של החברה:TherapeuticsMD TXMD
פריט של המותג TherapeuticsMD, Inc.

Since TherapeuticsMD, Inc. (TXMD) has lost its pricing power by becoming a royalty recipient, the company's forward P/E ratio reflects only market expectations for passive cash flows. This ratio correlates current market capitalization with projected earnings for the following year, allowing investors to assess the premium paid for future income and determine the risk of a correction in the event of inflated market expectations.